Tranzactioneaza Alpine Immune Sciences (US.ALPN) - 65 USD (%) Tranzactioneaza

1D
1W
1M
3M
6M
1Y
5Y
Max

Indici

Bid 62.00 USD
Ask 68.22 USD
Minim 64.21 USD
Maxim 64.95 USD
Pret referinta 65.00
Volum -
Volum ultima zi 1
Max 52 sapt 65.00 USD
Min 52 sapt 11.02 USD

Descriere companie

Alpine Immune Sciences, Inc. (www.alpineimmunesciences.com) is a biopharmaceutical company. The Company is focused on discovering and developing protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The Company's scientific platform uses a directed evolution process to convert native immune system proteins from the immunoglobulin super family (IgSF) into multi-targeted therapeutics capable of modulating the human immune system. Its product candidates include ALPN-101, ALPN-202 and ALPN-303. ALPN-101 is a dual inducible T cell costimulator (ICOS) and cluster of differentiation 28 (CD28) antagonist intended for the treatment of autoimmune and inflammatory diseases. Its oncology program is ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor intended for the treatment of cancer. ALPN-303 is a dual B-cell cytokine antagonist for the treatment of B-cell mediated diseases.

Informatii companie

Nume

Alpine Immune Sciences, Inc.